Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study: Ranjit Mohan Anjana et al, Lancet Diabetes
New Delhi, February 13, 2018: Sanofi Indiacontinues to deliver breakthrough medicines for the management of diabetes with the launch of its new product – Toujeo™,the next generation basal insulin. Toujeo™ is a once-daily,long-actingbasal analog insulin that improves glycemic control in adults with type 1 and type 2 diabetes.
Corporate Comm India(CCI Newswire)
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…
Nagpur, April 03, 2024: HCG Cancer Center Nagpur has launched a one-of-a-kind indigenous Asia`s first…
New Delhi, March 22nd, 2024: Manipal Hospital, Dwarka, in association with the Indian Academy of Pediatrics…